ISRCTN67590499已完成未知
Rifaximin in patients with portal hypertension due to schistosomiasis in Zambia: an open-label trial
niversity of Zambia (Zambia)0 个研究点目标入组 80 人开始时间: 2014年9月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
- 2018 results in https://www.ncbi.nlm.nih.gov/pubmed/29436337 (added 24/01/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Oesophageal varices
- •2. Schistosomiasis seropositive
排除标准
- •1. HIV seropositive
- •2. Cirrhosis
- •3. Hepatitis virus B or C infection
研究者
相似试验
Unknown
不适用
The Effect of Rifaximin on Portal Vein ThrombosisPortal Vein ThrombosisCirrhosisNCT03631147Shanghai Zhongshan Hospital96
Unknown
2 期
Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic PatientsPortal HypertensionLiver CirrhosisNCT01897051Yonsei University140
Unknown
2 期
Effect of Terlipressinum on the Portal Vein Pressure of Patients With Liver Tumor After Liver ResectionPortal Vein PressureNCT03352349Shanghai Zhongshan Hospital30
已完成
3 期
Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPSCirrhosisNCT02016196University Hospital, Toulouse211
Unknown
不适用
Efficacy and safety of SPILs 1301 tablets, 200 mg in subjects with travelers diarrhea : A Randomized, Double blind, Parallel group, Active and Placebo Controlled, Clinical Endpoint Bio equivalence StudyCTRI/2017/03/007996Sun Pharmaceutical Industries Limited1